HW
AMAG

Hancock Whitney’s AMAG Pharmaceuticals AMAG Stock Holding History

Hancock Whitney’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,549
Closed -$115K – 909
2019
Q2 		$115K Sell
11,549
-2,125
-16% -$22.9K ﹤0.01% 829
2019
Q1 		$176K Buy
13,674
+889
+7% +$13.2K 0.01% 796
2018
Q4 		$194K Sell
12,785
-2,255
-15% -$43K 0.01% 772
2018
Q3 		$301K Buy
+15,040
New +$342K 0.01% 756

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hancock Whitney's AMAG Position: Q3 2019 in Review

Hancock Whitney sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 11,549 shares — an estimated $115K sold.

Hancock Whitney first reported a position in AMAG in Q3 2018 and held it in 4 quarters. The position peaked at $301K in Q3 2018. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • Hancock Whitney reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Hancock Whitney sold 11,549 AMAG Pharmaceuticals shares in Q3 2019, an estimated $115K.
  • Hancock Whitney first reported a position in AMAG Pharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Hancock Whitney's AMAG Pharmaceuticals position peaked at $301K in Q3 2018.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Hancock Whitney's 13F filing for Q3 2019, filed 29 Oct 2019.